gnipst bulletin 46.4

03-07-2015

GGGNNNIIIPPPSSSTTT BBBUUULLLLLLEEETTTIIINNN 22200011155503rd July, 2015 Volume No.: 46 Issue No.: 04

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE

BASED LEARNING AND PRACTICE

Contents Message from PRINCIPAL Editorial board Historical article News Update Knowledge based Article Disease Related Breaking

News Upcoming Events Drugs Update Campus News Students Section Editors Note Archive

GNIPST Photo Gallery For your comments/contribution OR For Back-Issues, mailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

W e bs i t e : ht t p: / / gni ps t. a c. i n

03-07-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen. But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do. Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1

03-07-2015

EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE A brief history of pharmacist prescribing in the UK: Background Pharmacists have been prescribing in the UK since 2003, following the success of nurse prescribing. The review of prescribing, supply and administration of medicines (the second Crown Report) in 1999 proposed that new groups of professionals could apply for permission to prescribe in specific clinical areas.1 Pharmacists were among a number of professional groups, including nurses, midwives, physiotherapists, podiatrists, optometrists and radiographers, that were considered for enhancements to their prescribing rights.2 Pharmacists were the second group of health professionals to become non-medical prescribers, following nurses. Koci and Stewart argued that internationally, 24% of pharmacists were already undertaking some form of prescribing3; the UK approach is to provide a legal framework for roles that clinical pharmacists already undertake. The journey Pharmacists were first given prescribing rights (supplementary prescribing) in 2003 following the successful completion of a supplementary prescribing course at a UK school of pharmacy and subsequent registration with their regulatory body.4 The supplementary prescribing model was dependant on a prior diagnosis and an agreed and signed clinical management plan, developed in collaboration with the patient's general practitioner or hospital doctor (the independent prescriber), prescribing pharmacist, prescriber and the patient.1 Once this plan is in place,


2

03-07-2015

clinical responsibility and prescribing could be transferred to the supplementary prescriber from the doctor. Clinical management plans were individual to the patient but could.

NEWS UPDATE Live imaging reveals how wound healing influences

cancer: 01st July, 2015 Scientists have known for some time that inflammation is one of the ten hallmarks of cancer. Cancer has also been described as a "wound that does not heal." Now researchers have studied the 'see-through' larvae of zebrafish to reveal how wound healing leads to melanoma.

Miniature pump regulates internal ocular pressure: 01st July, 2015 Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, researchers are developing an implantable microfluid system that can efficiently and durably stabilize intraocular pressure.

Subcutaneous administration of multispecific antibody makes tumor treatment faster, more tolerable: 01st July, 2015 Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. According to the scientists, the findings could lead to shorter hospital stays, among other benefits for patients.


3

03-07-2015

New stem cell research uncovers causes of spinal muscular atrophy: 01st July, 2015 New research has used pioneering stem cell techniques to better understand why certain cells are more at risk of degenerating in Spinal Muscular Atrophy than others.

Stress urinary incontinence surgery debate: New evidence: 01st July, 2015 A new systematic review published today of surgery for stress urinary incontinence makes an important contribution to an ongoing debate and will help women to make more informed choices about treatment. Inserting a 'mid-urethral sling', a type of tape, to support the muscles of the bladder by either the groin or abdomen results in similar cure rates. However, differences in complications and the long term need for repeat surgery mean that women will need to balance a number of different factors when choosing an operation.

REM sleep critical for young brain development; medication interferes: 03rd July, 2015 Rapid eye movement or REM sleep actively converts waking experiences into lasting memories and abilities in young brains, reports a new study. The finding broadens the understanding of children's sleep needs and calls into question the increasing use of REM-disrupting medications such as stimulants and antidepressants.


4

03-07-2015

Novel DNA repair mechanism brings new horizons: 03rd July, 2015 The DNA molecule is chemically unstable giving rise to DNA lesions of different nature. That is why DNA damage detection, signaling and repair, collectively known as the DNA damage response, are needed. A group of researchers has discovered a new mechanism of DNA repair, which opens up new perspectives for the treatment and prevention of neurodegenerative diseases.

Infection with Wolbachia bacteria curbs fighting among fruit flies: 02nd July, 2015 Male fruit flies infected with the bacterium, Wolbachia, are less aggressive than those not infected, according to research. This is the first time bacteria have been shown to influence aggression.

For detail mail to editor

KNOWLEDGE BASED ARTICLE Vaccines and treatment for dengue virus possible

The finding, reported in the journal could lead to the first effective therapies and vaccines against dengue, a complex of four distinct but related mosquito-borne viruses that infect about 390 million people a year and which are a leading cause of illness and death in the tropics. "Scientists in the antibody discovery group of the Vanderbilt Vaccine Center continue to make great strides in developing novel antiviral drugs, such as this human antibody that not only kills dengue virus but also prevents enhanced dengue disease," said co-corresponding author and center director James Crowe Jr., M.D., Ann Scott Carell Professor.


5

03-07-2015

The four "serotypes" of dengue are distinguished by different antigens, or proteins on the viral envelope that elicit immune responses. What makes dengue so challenging, and so dangerous, is that antibodies generated against one serotype do not protect against the others. In fact, they actually can enhance infection by a second serotype, a process known as antibody-dependent enhancement (ADE) of infection. Sequential infections increase the risk for dengue hemorrhagic fever and dengue shock syndrome, characterized by fever, vomiting, internal bleeding and potentially fatal circulatory collapse. The researchers previously generated human monoclonal antibodies in the lab against a complex epitope, or antigenic portion of the viral envelope. In the current study, they used cryo-electron microscopy to freeze samples at very low temperatures so they could visualize antibody-antigen binding almost down to the atomic level. In this way they were able to identify a human monoclonal antibody against dengue virus type 2 (DENV2) that "locked" across an array of envelope proteins. In a mouse model, this prevented the virus from fusing to its target cell, thus it prevents infection. The antibody also was remarkable in that it has a second major function -- it blocks the binding of the other class of antibodies that otherwise would enhance infection. This specific "epitope," or portion of the envelope proteins elicits a specific immune response, thus it is a potential target for the development of dengue vaccines and therapeutics, the researchers concluded.

Jeenatara Begum Assistant Professor

GNIPST


6

03-07-2015

DISEASE RELATED BREAKING NEWS Middle East Respiratory Syndrome coronavirus

(MERS-CoV) Saudi Arabia: 03rd July, 2015 Between 19 and 30 June 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 6 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Read more

UPCOMING EVENTS 61st IPSF World Congress sponsored by Indian Pharmaceutical

Association (IPA) at Marriott Hotel, Hyderabad, India is going to on 30th July to 9th August, 2015.

For further details please visit www.ipsf2015.org

DRUGS UPDATES FDA Approves Orkambi (lumacaftor/ivacaftor)

for Cystic Fibrosis: 02nd July, 2015 The U.S. Food and Drug Administration today approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation.

Read more

CAMPUS NEWSFAREWELL PROGRAMME:

On 15th May 2015 GNIPST clebrated the farewell programme Sesh Chithi for the final year students of M.Pharm, M.Sc, B.Pharm, B.Sc and BHM.

JIS SAMMAN 2015


7

03-07-2015

On 11th May, 2015 GNIPST attended the JIS SAMMAN 2015. JIS SAMMAN Awards: Best College (Non Engineering):

GNIPST Best Principal:

Dr (Prof.) Avijit Sengupta Best HOD:

Mr. Jaydip Ray Best Faculty:

Mr. Debabrata Ghoshdastidar (Pharmacy)Dr. Swati Chakraborty (Life Sciences)

Best faculty since inception:Mr. Jaydip Ray

Best Office Staff:Ms. Jaya Banerjee

Best technical Assistant:Mr. Somnath Majhi

College Blue:Avik Paul

Highest DGPA of 2014:B.Pharm:

Purbali Chakraborty (4th year) Diksha Kumari (3rd year) Aishika Dutta (2nd year) Sampita Paul (1st year) M.Pharm: Aritra Mukherjee (Pharmaceutical Chemistry) Mounomukhar Bhattacharya (Pharmacology) B.Sc (Biotechnology): Papiya Saha (3rd year) Shomasree Das (2nd year) Ayanita Basak (1st year) B.Sc (Microbiology): Bonhisikha Chatterjee (3rd year)


8

03-07-2015

Riaz Hossain (2nd year) Soumi Chowdhury (1st year) BHM: Bishal Roy (3rd year) Shreyabhanja Chowdhury (2nd year) Recitation:

Udita Majumder Debate:

Srijita Roy Poushali Ganguly Quiz:

Arani ray Dipayan Nath Band:

Syantan Ghoswami Anurag Ghosh Atanu Mondal Arka Khamaru Ritobroto Paul Abhirup Dasgupta

Fashion: Md. Nadeem Shah Koustav Sarkar Shaksar Saha Avirup Dasgupta Ranit Kundu Namrata Ganguly Shreyasee Mitra Chandrika Saha Debopriya Chatterjee Riya Taran

Innovative Modeling: Ankit Chowdhury Kartik Koley


9

03-07-2015

Mudasar Manna Dipan Chaterjee Abhishek Singh Kaustav Pal Manojit Dutta SPIRIT JIS 2015

On 03th to 05th April, 2015 JIS organised SPIRIT JIS 2015. GPAT 2015 Result:

The following B.Pharm. final year students have qualified, GPAT-2015. We congratulate them all. Diksha Kumari Rupanjay Bhattacharya Avik Paul Xtasy 2015: GNIPST is going to organize the Tech Fest Xtasy 2015 from 30th March, 2015 to 1st April, 2015.

FINISHING SCHOOL TRAINING PROGRAMME: The FINISHING SCHOOL TRAINING PROGRAMME is going to organize by the Entrepreneurship Development Cell and Training & Placement Cell, GNIPST in collaboration with Indian Pharmacy Graduates Association (IPGA), Bengal Branch from 21st February to 11th April, 2015 at GNIPST Auditorium. On 21

st February, 2015 the Finishing School Training Programme of

GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy Director, Drug Control Office, Goutam Kr. Sen, President, IPGA, Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr. Ranendra Chakraborty, Sales Manager and Associate Director Dr. Reddys Laboratory. On 28th February, 2015 Dr. D. Roy, Former Deputy Drug Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager, Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning & Development, Cipla delivered their valuable lectures in the 2nd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.


10

03-07-2015

On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager, QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager, Operation, Ranbaxy Laboratory Limited delivered their valuable lectures in the 3rd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President (Quality Assurance), Albert David Ltd. delivered his valuable lectures in the 4th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of Jadavpur University and presently associated with NIPER delivered his valuable lectures in the 5th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 11th April, 2015 the closing ceremony of the FINISHING SCHOOL TRAINING PROGRAMME was held in GNIPST Auditorium. JOBS:

All the students of Final Year B. Pharm and M. Pharm are hereby informed that an interview will be conducted on 23rd May, 2015 by Standard Pharmaceuticals Ltd. GSK for post: Production, QA, QC. All the students of Final Year B. Pharm and M. Pharm are hereby informed that an interview will be conducted by GSK for sales and marketing job. Details given below:

Date: 27.03.2015Time: 09:45 amVenue : GSK Consumer Healthcare Limited, Unit No. 208,

2nd Floor, Ecospace Campus B (3 B), New Town, Rajarhat, 24 Pgs (N). Kolkata-700156.

THYROCARE provisionally selected 15 students from JIS Group. Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc Biotechnology have been selected. Ipsita Mondal (M. Sc Biotechnology)Debriti Paul (M. Sc Biotechnology)Debopriya Chatterjee {B. Sc (H) Biotechnology}


11

03-07-2015

The final year students of B.Pharm (31 students) and B.Sc (11 students) attended the pooled campus drive of Abbott India Ltd. on 10th March, 2015 at Jadavpur University. Among them 17 students have gone through to the final round of this pooled campus drive and short listed for final selection.

ACHIEVEMENT: Congratulations to Anurag Chanda, student of B.Pharm final year

who have got the 1st prize in poster presentation event in Prakriti 2015 at Department of Agricultural and Food engineering, IIT, Kharagpur.

OTHERS: On 24th and 25th February, 2015 Swamiji of Gourio Mathwasdelivered some motivational lectuers in GNIPST.

The students of GNIPST participated in the 4th Sardar JodhSinghTrophy organised by NIT on 20th February, 2015. On 8th February, 2015 Gnipst celebrated the ReunionprogrammeReminiscence Reloaded 2015.

STUDENTS SECTION WHO CAN ANSWER FIRST????

The original name of which author isCharles Lutwidge Dodgson?

Answer of Previous Issues Questions: Tanzania


12

03-07-2015

Identify the person

Answer of Previous Issues Image: Nek Chand Saini

Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at [email protected] NOTE

It is a great pleasure for me to publish the 4th issue of 46th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are able to avail the bulletin through facebook account GNIPST bulletin I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue.

ARCHIVE


13

03-07-2015

The general body meeting of APTI, Bengal Branch has beenconducted at GNIPST on 15th June, 2012. The program started witha nice presentation by Dr. Pulok Kr. Mukherjee, School of NaturalProducts, JU on the skill to write a good manuscript forpublication in impact journals. It was followed by nearly two hourlong discussion among more than thirty participants on differentaspects of pharmacy education. Five nonmember participantsapplied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT forconducting the two years post graduate course (M.Pharm)in PHARMACOLOGY. The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to120.

AICTE has sanctioned a release of grant under ResearchPromotion Scheme (RPS) during the financial year 2012-13toGNIPST as per the details below:a. Beneficiary Institution: Guru Nanak Institution of PharmaceuticalScience & Technology.

b. Principal Investigator: Dr. LopamudraDutta.c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d. Approved duration: 3 yearse. Title of the project: Screening and identification of potential

medicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants.


14

03-07-2015

Activity Clubs of GNIPST: Name of Club Member Faculty SPORTS Mr. Debabrata GhoshDastidar LITERARY AND PAINTING Ms. Jeenatara Begum SCIENCE AND INNOVATIVE MODELLING

Mr. Samrat Bose

ECO Ms. Sumana Roy SOCIAL SERVICES Dr. Asis Bala PHOTOGRAPHY Ms. Sanchari Bhattacharya CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya


15

A brief history of pharmacist prescribing in the UK:BackgroundThe journey

Live imaging reveals how wound healing influences cancer: 01st July, 2015Scientists have known for some time that inflammation is one of the ten hallmarks of cancer. Cancer has also been described as a "wound that does not heal." Now researchers have studied the 'see-through' larvae of zebrafish to reveal how wound healing... Miniature pump regulates internal ocular pressure: 01st July, 2015Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, researchers are developing an implantable microfluid system th... Subcutaneous administration of multispecific antibody makes tumor treatment faster, more tolerable: 01st July, 2015 New stem cell research uncovers causes of spinal muscular atrophy: 01st July, 2015 Stress urinary incontinence surgery debate: New evidence: 01st July, 2015 REM sleep critical for young brain development; medication interferes: 03rd July, 2015Rapid eye movement or REM sleep actively converts waking experiences into lasting memories and abilities in young brains, reports a new study. The finding broadens the understanding of children's sleep needs and calls into question the increasing use ... Novel DNA repair mechanism brings new horizons: 03rd July, 2015The DNA molecule is chemically unstable giving rise to DNA lesions of different nature. That is why DNA damage detection, signaling and repair, collectively known as the DNA damage response, are needed. A group of researchers has discovered a new mech...

Infection with Wolbachia bacteria curbs fighting among fruit flies: 02nd July, 2015For detail mail to editor

KNOWLEDGE BASED ARTICLEVaccines and treatment for dengue virus possible Middle East Respiratory Syndrome coronavirus (MERS-CoV) Saudi Arabia: 03rd July, 2015Between 19 and 30 June 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 6 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection.Read more FDA Approves Orkambi (lumacaftor/ivacaftor) for Cystic Fibrosis: 02nd July, 2015 CAMPUS NEWS STUDENTS SECTION

gnipst bulletin 46.4

Documents